Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alan Burnett, MD
Cardiff University- School of Medicine
Principal Investigator - Bob Lowenberg, MD
Erasmus Medical Center
Principal Investigator - Hartmut Doehner, MD
University Hospital Ulm
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospital Ulm
Ulm, Germany
- Erasmus Medical Center
Rotterdam, Netherlands
- Cardiff University
Cardiff, Heath Park, United Kingdom
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- James Cancer Hospital
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2011
- Primary completion
- 28 Feb 2013
- Completion
- 31 Mar 2013
- Last update posted
- 29 May 2013
- Registered enrollment
- 264
- Registry id
- NCT01463410
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.